Prostate Cancer

Robert G. Bristow, MD, PhD, on Prostate Cancer: Keynote Lecture

Photos From the 2018 Gastrointestinal Cancers Symposium, San Francisco

The 2018 Gastrointestinal Cancers Symposium was held recently in San Francisco. 

Watch for coverage of these sessions and more in upcoming issues of The ASCO Post or on ASCOPost.com. The 2018 Gastrointestinal Cancers Symposium was supported by ASCO, the American Society of Radiation...

Advertisement

U.S. Incidence and Projected Rise of Merkel Cell Carcinoma

The number of U.S. cases of Merkel cell carcinoma is rising about six times faster than most other cancers, and at nearly twice the rate of melanoma. Paulson et al reported these findings in The Journal of the American Academy of Dermatology, which are based on research conducted at the University...

Pancreatic Cancer

Ramesh K. Ramanathan, MD, on Metastatic Pancreatic Cancer: Results From a SWOG Study

Fox Chase Researchers Earn Privately Funded Grants for Five Pilot Projects

 

Neil Johnson, PhD

Neil Johnson, PhD

 

 

Richard Pomerantz, PhD

Richard Pomerantz, PhD

 

 

Vasily Studitsky, PhD

Vasily Studitsky, PhD

 

 

 Italo Tempera, PhD

Italo Tempera, PhD

 

Kuang-Yi Wen, PhD

Kuang-Yi Wen, PhD

 

The Fox Chase Cancer Center is pleased to announce the first winners of its new privately funded pilot project grants. The...

Solid Tumors

Pembrolizumab in MSI-H or dMMR Solid Tumors: ‘First Tissue/Site-Agnostic’ Approval by FDA

 

On May 23, 2017, pembrolizumab (Keytruda) was granted accelerated approval for treatment of adult and pediatric patients with unresectable or metastatic microsatellite instability–high (MSI-H) or mismatch repair deficient (dMMR) solid tumors progressing following prior treatment and who have no...

Serum Bone Biomarkers in Early Breast Cancer and Risk of Bone Metastasis

In a study reported in the Journal of the National Cancer Institute, Brown et al found that the serum bone biomarkers P1NP, CTX, and 1-CTP showed good prognostic ability for bone metastasis in patients in the phase III AZURE (BIG01/04) trial of adjuvant zoledronic acid in early breast cancer.

...

Gastroesophageal Cancer

David H. Ilson, MD, PhD, on Improving Esophageal Cancer Outcomes: Future Directions

Four New Scientists and Researchers Join City of Hope

City of Hope recently announced the appointments of four new scientists to its research faculty.

Jianjun Chen, PhD, joins the staff as Professor and Vice Chair of the Department of Systems Biology. Before joining the Beckman Research Institute of City of Hope, Dr. Chen had been serving as...

Advertisement

Dose Rounding of Anticancer Agents: Hematology/Oncology Pharmacy Association Position Statement

As reported in the Journal of Oncology Practice by Fahrenbruch et al, the Hematology/Oncology Pharmacy Association (HOPA) has issued a position statement on dose rounding of biologic and cytotoxic anticancer agents.

To formulate the position statement, the HOPA standards committee organized a work ...




Advertisement

Advertisement



Advertisement